Literature DB >> 34280586

Treatment of severe atopic dermatitis and eosinophilic esophagitis with dupilumab in a 14-year-old boy with autosomal dominant hyper-IgE syndrome.

Cheshil Dixit1, Akaluck Thatayatikom2, Helen Pappa3, Alan P Knutsen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34280586     DOI： 10.1016/j.jaip.2021.06.049

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  6 in total

Review 1.  Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review.

Authors:  Tejas P Joshi; Hannah Y Wang; Prazwal Athukuri; Sarah Bohac; Morgan A Farr; Darien Hinson; Justin A Kahla; Nasim Khalfe; Dylan B McBee; Rachel Stroh; Nicole Walters; Vicky Ren
Journal:  Am J Clin Dermatol       Date:  2022-05-23       Impact factor: 6.233

2.  Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency.

Authors:  H Richard Droghini; J Pablo Abonia; Margaret H Collins; Joshua D Milner; Jonathan J Lyons; Alexandra F Freeman; Vincent A Mukkada; Kimberly A Risma; Marc E Rothenberg; Justin T Schwartz
Journal:  J Allergy Clin Immunol Pract       Date:  2022-01-29

Review 3.  Mechanisms and clinical management of eosinophilic oesophagitis: an overview.

Authors:  Luc Biedermann; Alex Straumann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-10-17       Impact factor: 73.082

4.  Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review.

Authors:  Jun Lan; Yi Zhang; Min Song; Shan Cai; Hong Luo; Ruoyun OuYang; Pan Yang; Xiaoliu Shi; Yingjiao Long; Yan Chen
Journal:  Front Med (Lausanne)       Date:  2022-05-04

5.  Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome.

Authors:  Caterina Matucci-Cerinic; Gianmaria Viglizzo; Carlotta Pastorino; Anna Corcione; Ignazia Prigione; Paola Bocca; Marta Bustaffa; Massimiliano Cecconi; Marco Gattorno; Stefano Volpi
Journal:  Pediatr Allergy Immunol       Date:  2022-04       Impact factor: 5.464

6.  Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry.

Authors:  Paulina Tran; Laura Gober; Elizabeth K Garabedian; Ramsay L Fuleihan; Jennifer M Puck; Kathleen E Sullivan; Jonathan M Spergel; Melanie A Ruffner
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.